Intervet/Schering-Plough has launched Vectin chewable tablets, an ivermectin wormer for horses which is administered as a treat straight from the hand rather than in the traditional paste or granule formulation.
According to the company, syringe handling, horse acceptance and the tendency to spit out some or all of the paste are common problems reported by owners when worming their horses, and more than 55% admit that these issues can result in a mixture of emotions, including frustration, anxiety and upset.
Field studies with Vectin showed more than 70% spontaneous acceptance by horses and the simple calculation of one tablet for every 110kg of a horse or foal's bodyweight helps to reduce wastage as unused tablets can be stored away for future use.
Pharmacokinetics studies have demonstrated improved bioavailability (AUC) and maximal concentration (Cmax) when compared with an equivalent competitor ivermectin paste formulation. Trials have also shown that a more consistent blood concentration of ivermectin when given as a chew which could potentially limit the chance of inducing resistance.
Intervet/Schering Plough says that used as part of a strategic worming plan, Vectin chewable tablets control potentially a wide range of endoparasites including small and large strongyles, stomach worms, cutaneous worms and stomach bots.
Vectin chewable tablets are available as a seven-tablet blister pack, perfect for treating a horse or a couple of ponies. For yards, a tub of 60 tablets is available, containing enough to dispense product for worming approximately 12 horses.
Vectin chewable tablets are recommended for use alongside Pyratape P and Panacur in Intervet/Schering-Plough Animal Health's Active3 worming plan, a strategic three-year approach to rotating wormers in order to minimize the risk of resistance developing. Visit http://www.intervet.co.uk/ for a copy of the three-year plan.
Dr. Tracy Hill, a specialist in internal medicine, has joined the Royal (Dick) School of Veterinary Studies, bringing with her expertise in interventional radiology.
Tracy completed a fellowship in interventional radiology and endoscopy at the Animal Medical Centre in New York, will be researching new techniques in this developing field.
She will also work in the clinic at the School's Hospital for Small Animals and as a senior lecturer.
She said: "Interventional radiology is an emerging and expanding area in veterinary medicine. Interventional radiology employs the use of fluoroscopy and endoscopy to enable minimally invasive treatments for diseases in many body systems. These techniques often reduce morbidity, mortality, or cost associated with more invasive procedures. The Dick Vet has been performing interventional cardiac procedures for some time and we are looking to expand this field into treatment of non-cardiac diseases."
Tracy, who carried out her residency in small animal internal medicine at North Carolina State University, where she also completed a PhD, will help the Royal (Dick) School of Veterinary Studies at the University of Edinburgh to provide interventional radiology procedures.
This includes a minimally invasive treatment for certain liver shunts using a procedure only being regularly performed at a handful of veterinary hospitals in the world. In this procedure, fluoroscopic guidance is used to access the abnormal vessels in the abdomen via a catheter placed in the jugular vein in the neck. The abnormal shunt vessel is then closed using coil embolization, without the need for abdominal surgery.
Tracey said: "I am delighted to join the Dick Vet. There is no denying the expertise at the vet school, as well as its partnership with The Roslin Institute for research."
Almost all rabies cases are as a result of being bitten by an infected dog, with around half of all dog bites and rabies deaths occurring in children under 15 years of age. Rabies, which is preventable, is categorised as one of the 17 Neglected Tropical Diseases by the World Health Organization (WHO).
The End Rabies Now campaign aims to significantly raise the profile of rabies as a global neglected tropical disease with policy makers and journalists, explaining what is being done to control and eliminate the disease. The campaign is led by Global Alliance for Rabies Control (GARC), and has three key messages:
Ahead of the tenth World Rabies Day, BVA has also recognised vet Professor Sarah Cleaveland OBE for her work in rabies control by awarding her the Chiron Award, one of the Association’s most prestigious awards for outstanding contributions to veterinary science.
Sarah said: "Awards like this are recognition of the contributions not only of one person, but the work of many. We are deeply committed to continuing our efforts towards the global elimination of canine rabies and tackling other zoonotic diseases that affect the health and livelihoods of many of the poorest people in the world."
The End Rabies Now campaign is based around the strong scientific evidence that vaccinating dogs is fundamental to disrupting the cycle of rabies transmission to humans. The target of 2030 was chosen because one of the UN’s sustainable development goals, launched in September 2015, includes the ambition to end by 2030 neglected tropical diseases such as rabies.
With 120 countries still affected by canine rabies, the End Rabies Now campaign advocates that collaborative cross-sector efforts are needed to end zoonotic diseases such as rabies: rabies elimination plans must include human and animal government agencies, veterinary and human health professionals, educators, scientists and community groups.
BVA President Gudrun Ravetz said: "The work being done worldwide by vets, human health professionals and others to combat this horrific disease that senselessly kills thousands each year is of the utmost importance and BVA is proud to support the End Rabies Now campaign and help get those key messages out to policy makers and governments worldwide – every rabies death is entirely preventable and we can end rabies by 2030 through vaccinating dogs."
The training will take place in locations across BSAVA’s regional network in the UK, and is open to large, small, and equine veterinary teams.
The sessions will cover the complexity of abuse and the impact of domestic abuse on children, how to recognise abuse/non-accidental injury in animals, how to document information and what to do when dealing with disclosure from a human victim of abuse.
They will also give guidance on setting up a practice protocol and identifying a practice links adviser who will assist those involved in the veterinary team to manage suspected cases of abuse.
Invited guests will include representatives from human and veterinary health, welfare bodies and policy makers.
Vicki Betton, Vice-Chair of The Links Group said: “We’re thrilled to be rolling out our programme of in-person training days with BSAVA.
"Abuse of any vulnerable member of the family, human or animal, is a difficult subject for many to even consider, but with reported cases of domestic abuse reaching an all-time high during the pandemic, its essential that teams are aware of the issue and have a practice protocol in place for if they feel something isn’t quite right with a case.
“We’re looking forward to exploring the most effective ways veterinary teams can recognise and act on suspected cases of non-accidental injury or disclosures of domestic or child abuse.”
The training days are free for BSAVA members and £50 (inc VAT) for non members.
So far, dates have been confirmed for Nottingham on 18th April and Exeter on the 29th June. Others are planned for the Metropolitan, Southern, Wales and North West regions.
To book your place, visit: https://www.bsava.com/education/cpd/regional-cpd
Veterinary training provider Improve International has opened training facilities at its new European head office, near Swindon.
The company says its relocation to Alexandra House Conference Centre is a strategic move, allowing it to offer residential courses, new programmes and extended courses, as it challenges the industry to re-think its approach to Continuous Professional Development (CPD) and postgraduate qualifications.
Nick Fowler, General Manager of Improve International said: "As a training company founded by vets for vets, we want to harness the passion and experience which can be found throughout the profession and nurture a desire for lifelong learning.
"Training shouldn't become a CPD 'tickbox' that's cumbersome to fit around practice commitments. That's why we have moved towards a far more flexible modular programme, where we can design a personal development plan around an individual's career aspirations - whether they are vets in general practice, vets with special interests, a veterinary nurse, or a practice manager.
"Having the very best facilities in which to train is integral to this plan, so having outgrown our centre in Cricklade, we were keen to find new premises which would meet all our needs. Although it's an unusual scenario to move into an established conference and events centre, we felt that the facilities offered by Alexandra House - from the fully serviced training rooms to the uniquely designed practical suite, 5 star bedrooms, acres of grounds, on-site leisure complex and great food - would all enhance the training experience of our delegates."
A separate wing of Alexandra House has been converted into Improve International's office space, training rooms and a 700 square feet state-of-the-art practical facility which the company says will be one of the finest available in Europe.
Improve International will open a second sister centre at Cranage Hall in Cheshire, also part of the Principal Hayley conference group, within the next 12-months.
Information about courses and facilities is available at www.improvecpd.com
The BSAVA has launched the BSAVA Manual of Canine and Feline Radiography and Radiology with a new introductory text aimed at veterinary students, nurses and new graduates.
The Association says confident radiographic interpretation presents a considerable challenge and the BSAVA Manual of Canine and Feline Radiography and Radiology provides a comprehensive review of the approach to radiological interpretation, the range of variants and the key fundamental principles and their application to common diseases.
The manual features high quality radiographic reproductions demonstrating normal anatomy and key aspects of interpretation, as well as illustrations showing patient positioning and the practical approach that is the hallmark of the BSAVA manuals.
The book contains the following contents:
An extra feature is the CD, which contains all the radiographic images from the manual, so that readers can view the many images at an enlarged size.
The manual is available from October and can be ordered from www.bsava.com.
The aim of the week is to focus equine practices on ‘Taking care of the small things that make a big difference’ with a toolkit of resources designed to help them promote their businesses and educate and promote the benefits of preventative healthcare.
Peter Young, MSD Equine Business Manager said: "This year’s Horse Health Week has been created to focus on the small things we can all do to help keep our nation’s horses happy and healthy. We are encouraging equine vets to get involved and engage with their clients throughout the week with the support of our toolkit. This celebration of Britain’s horses and the things we can do to improve their health is a positive opportunity for vets to build client loyalty and attract new clients. I urge practices to do as little or as much as they can, but I urge them to do something!"
Horse Health Week is supported with a range of materials for both practices and clients, along with social media content, which vets can obtain on a USB stick from their MSD Animal Health Equine representative.
The toolkit includes a series of five animations – one for each day of the week. They each cover a different topic including; horse connections, the importance of hand washing, equipment at shows, isolation and vaccination. There is also a social media campaign for practices to run called #BonVoyageBuzz, and a survey that will gather the views of horse owners on preventative healthcare.
For full details talk to your MSD Animal Health Account Manager, call MSD on 01908 685685 or refer to www.healthyhorses.co.uk/horse-week.
The project looked first at how effective CVS small animal first opinion practices were at conducting echocardiography.
It found that a barrier to wider uptake was a lack of up-to-date equipment, along with a lack of current knowledge and training - both in using ultrasound and echocardiography equipment and in interpreting images.
CVS says that as a result, many colleagues were routinely referring suspected cardiac disease cases.
The project leaders then reviewed and recommended practice equipment, so that clinicians had the tools to perform echocardiograms in practice.
This included buying echocardiography tables - so that practitioners could scan an animal’s chest from underneath, more advanced cardiac ultrasound machines and electrocardiogram (ECG) machines.
The company then produced a range of resources for vets and nurses, to help them to improve echocardiography scan rates and nurse cardiology clinics, including clinical guidelines, machine guides and client resources.
It then held a number of training sessions for its vets and nurses, focusing on the latest advancements in heart disease diagnosis and treatment for vets, and training nurses how to conduct nurse cardiology clinics, how to perform and interpret electrocardiography, how to take blood pressure readings and thoracic point of care ultrasound (POCUS).
Lynsay Morgan, Regional Clinical Lead at CVS who is responsible for the cardiac ultrasound clinical improvement project, said: “We want to empower our first opinion small animal vets to perform more echo evaluations and to work up their cardiology cases to a high standard.
"We also want our nurses to be involved in patients’ life-long care, and provide ongoing support to owners of pets with heart disease.
“We hope this project will improve case identification, increase skills and confidence, and see optimum diagnosis and management of cardiac disease.”
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
Following the announcement last month of the establishment of a Working Party to review Extra-Mural Studies (EMS) in the undergraduate veterinary degree, the Royal College of Veterinary Surgeons is inviting comment from all those involved with organising, providing and receiving EMS.
Opinions are not being sought in response to a set of formal questions, but respondents may like to consider the strengths and weaknesses in the system; problems and possible solutions; and what should be retained and what could change.
Written comments should be sent to Freda Andrews, Head of Education at the RCVS, on education@rcvs.org.uk by 16 February 2009.
This call for input is the first of several phases of activity that will lead to the delivery of a report from the Working Party to the RCVS Education Policy and Specialisation Committee in October 2009. Following this initial information-gathering stage, some individuals and organisations will be invited to deliver their views in person to the Working Party during April.
Draft recommendations will then be formatted for any change to the current system, which requires that veterinary students undertake pre-clinical and clinical work experience placements for at least 38 weeks during their degree course. A further consultation process may follow, depending on the nature of the recommendations, before the paper is finalised.
Dr Barry Johnson, RCVS Council member and Chairman of the EMS Working Party said: "It is over 10 years since the RCVS undertook a major review of EMS, although the requirements and guidelines were revised and updated in 2005 to introduce more flexibility for universities to meet the individual learning needs of their students.
"In recent years, there have been significant changes in the UK higher education system, the veterinary curriculum and the organisation of veterinary schools, and the time is now right for a more substantial review."
Genitrix has launched Dentagen toothpaste which, the company says, uniquely both cleans teeth and inhibits the formation of plaque.
Dentagen toothpaste is based on RF2, a plant extract, which is clinically proven to inhibit the formation of dental biofilm or plaque. It has been formulated to a dentrifrice abrasivity (RDA) index of 34 to ensure that it removes plaque while causing no damage to the enamel layer of the teeth. The toothpaste is packaged with a free finger-brush to help introduce the pet to having its teeth brushed. It costs £5.50 for a 70g tube.
The toothpaste completes the range of Dentagen health products - the fastest growing dental products in the UK (according to GFK data in May 2010).
Genitrix says Dentagen is the only veterinary dental system to combine a procedure carried out in practice with a variety of aftercare regimes to ensure owner compliance. In 2008, Genitrix launched the Dentagen plaque protection system. It consists of a RF2-impregnated wax provided to practices in a syringe and applied to the gingival layer and the buccal area of teeth of dogs or cats at the end of dental procedures. Pet owners then maintain the protective coating by using the new Dentagen toothpaste or other products in the range - either the RF2-impregnated vegetable-based palatable Dentagen chews or Dentagen Aqua, a palatable liquid containing RF2, which is added to a pet's drinking water on a daily basis.
Rob Watkins, Genitrix' Marketing Director, said: "Brushing has long been recognised as the 'gold standard' when it comes to dental health care so we felt it was important for the Dentagen range to include this option. Regular brushing makes a significant contribution to the maintenance of oral health and the RF2 in the Dentagen toothpaste actually suppresses plaque formation between brushing which is a further benefit. It sets a new efficacy standard for pet toothpaste.
However, while many owners understand the importance of dental health, many of them find actually brushing their pet's teeth difficult - especially those with cats. This is why the Dentagen range includes a variety of options. It enables pet owners to select the method that is right for them and their pet and thus maximise the likelihood of their compliance with a good preventive health regime."
The course explains what to expect if you’re a veterinary surgeon who has had a concern raised about them.
Clare Stringfellow, Case Manager in the RCVS Professional Conduct Team, said: "We appreciate that concerns can be very worrying, and we hope that, through this course, we can give vets and nurses a better understanding of the process and how to obtain additional support.
“The course will allow participants to understand the different stages involved and the key activities that happen at each point, as well as detailing some of the common concerns we receive and how these are dealt with.”
The CPD course, which includes film and audio content, takes about 30 minutes to complete.
https://academy.rcvs.org.uk
CVS says it believes the phone-based resource is a first in the profession.
It contains the ‘kennel side’ veterinary guidelines, notes and charts that clinicians would need to refer to in day-to-day companion animal practice.
It also includes clinical guidelines, anaesthesia, diagnostic imaging, dentistry and toxicology sections, along with an antibiotic guide.
CVS says it hopes the breadth of information in the MiGuide will improve and speed clinical decision-making, making recommendations to clients easier - and ultimately improving patient outcomes.
The hub is the brainchild of Alan Johnson, Regional Clinical Lead at CVS.
He said: “Every day in practice is different.
"You regularly have to do things you have not done for a while.
"So you either have to recall how to do them or spend time looking them up.
"This can be especially difficult when you are looking for very specific information which is buried in a textbook.
“I wanted to consolidate the key clinical information that every colleague needs every day - all in one location.
"I wanted to make information easy to find at a few clicks.
"And I wanted vets and nurses to have this information in their pocket – to refer to if the need arose.
“We hope our new portal is helpful and supportive – and makes daily practice smoother for our vets and nurses.
"And we hope that it improves and speeds up clinical decision-making to provide the best care for our patients.”
Dechra Veterinary Products has launched a webcast about feline hyperthyoidism, given by Tim Williams MA VetMB MRCVS from the Feline Research Group at the Royal Veterinary College.
During the ten minute webcast, entitled: 'The highs and lows of feline hyperthyroidism', Tim presents new evidence that overdosing hyperthyroid patients can lead to iatrogenic hypothyroidism, making them more likely to develop azotaemia and consequently have a shorter survival time. He also discusses the diagnosis and potential consequences of iatrogenic hypothyroidism based on recent research conducted at the Feline Research Group, and provides a summary of suggested treatment protocols. Tim said: "I hope the webcast helps veterinary staff optimise their treatment of hyperthyroid cats in practice and avoid a one size fits all approach".
Dechra says that research from 400 first opinion practices has shown that hyperthyroidism is the most commonly diagnosed feline endocrinopathy, with an annual incidence of 6% in cats over nine years old.
Tim's webcast is the latest in a series of online educational materials on endocrinology launched by Dechra as part of its Dechra Academy training suite.The webcast is available at http://www.dechra.co.uk/hyperthyroidism
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
The company says it is a further step forward in its plans to expand into Europe and follows the launch of its online pharmacy business, Animed Direct, into France during 2016. It adds that further acquisitions are expected in Europe during 2017, in addition to continued growth in the UK.
The two Dutch practices joining CVS are the Kliniek voor Gezelschaps Dieren, a three site small animal practice based in the central Netherlands, and a single site small animal practice, Dierenziekenhuis Drachten, based in the north of the country. Both practices cited the business support and staff development opportunities offered by CVS, combined with the clinical freedom and practice autonomy it allows, as the reasons for choosing to join the company.
Simon Innes, CEO at CVS, said: "We see many parallels between small animal practice in the Netherlands and the UK and have been talking to practices in the country about the benefits of joining us for some time. The level of interest has been encouraging and we are delighted to announce the acquisition of these two practices and welcome their teams to the CVS family.
"During 2017, we will continue to explore opportunities to extend our activities into Europe, particularly in the Netherlands and in Ireland."
The survey, which is being carried out throughout June, was also conducted back in 2016 and is now being repeated to identify any developments and outcomes that have been made over the past four years, a time in which several new epilepsy management options have emerged.
The survey asks vets to prioritise how important they feel different areas of epilepsy research are and assess how much they think new therapies might improve epileptic dogs’ lives. This includes emerging therapies like MCT oil, cannabidiol oil, vagus nerve stimulation and transcranial magnetic stimulation, for which studies are currently being conducted across the globe.
The aim of the survey is to identify the priorities for future research for owners, vets and neurologists alike, and to see if there are any differences in their priorities.
Dr Rowena Packer, BBSRC Research Fellow and research lead in canine epilepsy at the RVC, said: "This survey was inspired by similar prioritisation activities undertaken by the International League Against Epilepsy (ILAE) for human epilepsy patients. At the RVC, we believe that the benefits of such an open approach can be truly valuable for veterinary medicine too, and ensure a diversity of views influence future epilepsy priorities."
Dr Gareth Jones, Small Animal Intern at the RVC who is running the study, said: "While many have already undertaken the survey, we are keen to hear from more participants so I would like to implore any general practice vets to please help contribute to our work by taking part in our short survey."
To take part in this survey please visit www.rvc.uk.com/epilepsy-future, and do share this news story with colleagues. If you have any questions about the research, e-mail Dr Gareth Jones atgjones1@rvc.ac.uk.
Having sold Belgravia House – its Westminster offices since 1995 – to a private investor in March 2021 for £14.5m, RCVS Council agreed the purchase of the new building for £20.5m.
The additional cost has been funded from College reserves.
The new building is a converted Victorian warehouse with open-plan office space spread across six floors.
The new premises are large enough to accommodate more staff and for the College to host more meetings and events.
Alternatively, the space can be used for greater social distancing and hybrid working if needed.
The College says any unwanted space can be rented out.
Two existing tenants will continue to lease office space at the premises for the time being and some refurbishment work will need to be completed before the College and RCVS Knowledge teams can start moving in.
Following Council’s earlier decision to terminate the lease on Belgravia House at the end of March 2022, RCVS staff will continue to work either remotely, or in temporary office space leased from the workplace provider, WeWork, in Chancery Lane.
The College says this arrangement offers a significant saving over leasing back Belgravia House.
Chief Executive Lizzie Lockett said: “Like any property purchase, it has been an extremely long and difficult journey to get to this point, with many challenges to navigate along the way, but I am delighted that we are finally able to announce our new home.
“Whilst we will have to wait a while longer before we can enjoy everything 1-2 Hardwick Street has to offer, we are very much looking forward to welcoming members of the professions to visit our new offices, and being able to host a variety of meetings and new events there for them.
The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures and vaccination.
There will be a prize draw from completed entries and the winner will get two VIP tickets to Your Horse Live 2025.
Rachel Harrison-Osborne MRCVS, equine field manager at Dechra said: “The strangles survey will provide us with a valuable insight into horse owners’ experiences of the disease and will enable us to identify any trends that may exist to help us support owners who wish to put in place preventative measures to help prevent strangles.”
https://forms.office.com/e/85gzEd7J7A
Photo: Redwings Horse Sanctuary
Intervet reports that a clinical trial of 489 cows on dairy farms in the south west last spring and summer has demonstrated some excellent efficacy levels for treating and preventing intramammary infections in the dry period and early lactation.
The trial compared Cephaguard® DC and a 600mg cloxacillin dry cow tube (OEDC) on its own, and in combination with a teat sealant. Cephaguard DC demonstrated superior efficacy in terms of infection prevention during and after the dry period relative to cloxacillin alone, and was statistically equal to the combination treatment group.
Indeed, cows treated with cefquinome (Cephaguard DC) were around half as likely to develop mastitis in the first 100 days post calving than those treated with cloxacillin alone.
The trial also demonstrated excellent efficacy levels against existing Strep. uberis infections when compared with cloxacillin (see table).
DRY PERIOD CURE RATES (%) OF KEY MASTITIS PATHOGENS
Cephaguard DC
Cloxacillin (600mg)
Strep. uberis
100
75
E. coli
92.31
Coagulase +ive Staphs
66.67
S. dysgalactiae
Intervet’s large animal veterinary adviser Rosemary Booth said: "With Intervet’s Cephaguard bacteriology scheme showing that Strep. uberis is responsible for 18% of high cell counts and 23% of clinical cases, the dry period offers a fantastic time to treat this persistent pathogen."
She added: "Several weeks of exposure to an effective dry cow antibiotic provides a particularly good opportunity to kill the cow-adapted strain of Strep. uberis. It lives quite happily in the udder and is tougher and harder to kill than the environmental strain."
The cloxacillin-treated group was significantly more likely to develop clinical mastitis compared to the cefquinome-treated group, as is shown in the table below:
First quarter clinical mastitis cases up to 100 days post calving in quarters not sampled in transition
OEDC
Total major pathogens
12
21
Total with enterobacterial involvement
6
Total cases
26
41
According to Intervet, the study results suggest that reviewing dry cow therapy this summer, and moving to a cefquinome-based treatment may help reduce the incidence of mastitis. Further information on the study will be presented at the Large Herd Seminar on 30 June 2008 and is available from Intervet.
New research amongst veterinary professionals conducted by CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has revealed that pet owners may be unintentionally fuelling their pets' noise phobias in the run up to the fireworks' season.
According to CEVA's research, up to 95% react inappropriately, for example petting an anxious pet during firework exposure rather than making an effort to ignore the fireworks, thereby reassuring the animal by behaving normally.
The research also suggested that 77% of clients have never taken action to address their pets' noise phobias as fireworks' season is only an annual occurrence. This is despite evidence that noise phobias can affect pets all year round and tend to become worse over time.
In addition, if owners do seek advice from their vet for noise phobias, it is at the last minute. It is estimated that 46% of clients leave it until the day before the fireworks are due to start before seeking help.
Lucy Brett, product manager at CEVA Animal Health said: "Owners are not doing enough to reduce their pets' firework fears and prevent noise phobias from developing.
"Taking early, proactive action within the practice is the best way to help dogs with pre-existing firework phobias as well as those with mild fears which, if left untreated, may develop into more serious noise phobias."
CEVA Animal Health and Sound Therapy 4 Pets have once again joined forces with the Association of Pet Behaviour Counsellors (APBC), Feline Advisory Bureau (FAB) and PDSA to launch a 'Remember, remember your pets this November' campaign to provide owners with advice on how to look after their pets during the firework season and the precautions they should take to help them cope with their fear of fireworks.
The initiative features a wide range of advice including how to use synthetic copies of natural pheromones, D.A.P. ® and Feliway®, to help comfort and reassure fearful pets, creating a comforting den for dogs to retreat to during firework exposure and treating noise phobias using behavioural therapy with the Sounds Scary desensitisation CD (which is the only behavioural therapy product for noise phobias supported by the RSPCA).
For further information, please visit www.petfireworkfear.co.uk.
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
Kruuse has launched Krutex Polyisoprene Surgical Gloves, which are both powder and latex-free to minimise the risk of glove-related allergy to latex protein.
The gloves are made from synthetic polyisoprene, which has a molecular structure similar to natural rubber latex. This, says the company, means the gloves have a fit, sensitivity and comfort equal to natural rubber latex. The company says they are also designed to provide increased fingertip sensitivity.
Andrew Groom Managing Director, Kruuse UK Ltd said: "After feedback from our customers showed an increasing concern regarding latex allergies amongst clinicians, we were encouraged to develop this addition to our well established range of gloves."
Krutech latex free gloves join the existing Krutech range which includes; Vet Gel surgeons' gloves, Krutech latex surgical gloves, Krutech latex, vinyl and nitrile examination gloves and the widely used arm length gloves range. The new range is supplied in boxes of 25 sterile, single packed pairs and are available in half sizes from 6.0 to 9.0.
The questionnaire asks you about your perceptions of the PDP, with a focus on the guidance made available both by the RCVS and where applicable the resources provided by the BSAVA.
The company stresses that the survey is confidential, and results will be reported in aggregate only; no individual will be identified. It takes 5 minutes and the results will be used to help evaluate and improve the PDP in the future.
Graduates who are currently or have recently completed the PDP are invited to share their views on the PDP: http://app.keysurvey.co.uk/f/1141621/9038/
Employers / mentors of veterinary graduates are invited to share their views on the PDP here: http://app.keysurvey.co.uk/f/1141665/288d/